CD8A and tuberculosis: One such candidate, MTBVAC.HIVA2auxo, a live-attenuated vaccine for HIV-1 and TB elicited polyfunctional HIV-1-specific CD8+ T cells and interferon-γ-producing Mtb-specific T cells20 (Table 1).